In vivo and in vitro activity of genistein in osteoporosis

Indian Journal of Pharmacology

Volumn 39, Issue 2, 2007, Pages 103-106

  Wang, Jiepin ^a   Shang, Fujun ^b   Liu, Li ^a   Wang, Siwang ^a   Wang, Jianbo ^a   Mei, Qibing ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Genistein; MC3T3 E1 cells; Osteoporosis; OVX rats

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ALKALINE PHOSPHATASE; CALCIUM; GENISTEIN; PHOSPHORUS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DENSITY; CALCIUM BONE LEVEL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OSTEOPOROSIS; OVARIECTOMY; RAT;

EID: 34250215669     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: 10.4103/0253-7613.32529     Document Type: Article

References (21)

1. Arjmandi BH, Alekel L, Hollis BW, Amin D, Stacewicz-Sapuntzakis M, Guo P, et al. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 1996;126:161-7.
2. Barnes S. Phyto-oestrogens and osteoporosis: What is a safe dose?. Br J Nutr 2003;89:S101-8.
3. Olsson HL, Ingvar C, Bladstrom A. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden. Cancer 2003;97:1387-92.
4. Albertazzi P, Purdie D. The nature and utility of the phytoestrogens: A review of the evidence. Maturitas 2002;42:173-85.
5. Russell L, Hicks GS, Low AK, Shepherd JM, Brown CA. Phytoestrogens: A viable option?. Am J Med Sci 2002;324:185-8.
6. Coxam V. Prevention of osteopaenia by phyto-oestrogens: Animal studies. Br J Nutr 2003;89:S75-85.
7. Hidaka S, Okamoto Y, Miyazaki K, Uesugi T. Evaluation of a soybean product fujiflavone P40 as an antiosteoporotic agent in rats. Phytother Res 2003;17:112-9.
8. Lee YB, Lee HJ, Kim KS, Lee JY, Nam SY, Cheon SH, et al. Evaluation of the preventive effect of isoflavone extract on bone loss in ovariectomized rats. Biosci Biotechnol Biochem 2004;68:1040-5.
9. Mathey J, Puel C, Kati-Coulibaly S, Bennetau-Pelissero C, Davicco MJ, Lebecque P, et al. Fructooligosaccharides maximize bone-sparing effects of soy isoflavone-enriched diet in the ovariectomized rat. Calcif Tissue Int 2004;75:169-79.
10. Ososki AL, Kennelly EJ. Phytoestrogens: A review of the present state of research. Phytother Res 2003;17:845-69.
11. Lonard DM, Smith CL. Molecular perspectives on selective estrogen receptor modulators (SERMs): Progress in understanding their tissue-specific agonist and antagonist actions. Steroids 2002;67:15-24.
12. Crisafulli A, Altavilla D, Squadrito G, Romeo A, Adamo EB, Marini R, et al. Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin system in early postmenopausal women. J Clin Endocrinol Metab 2004;89:188-92.
13. Cotter A, Cashman KD. Genistein appears to prevent early postmenopausal bone loss as effectively as hormone replacement therapy. Nutr Rev 2003;61:346-51.
14. Muthyala RS, Ju YH, Sheng S, Williams LD, Doerge DR, Katzenellenbogen BS, et al. Equol, a natural estrogenic metabolite from soy isoflavones: Convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorg Med Chem 2004;12:1559-67.
15. Chen X, Garner SC, Quarles LD, Anderson JJ. Effects of genistein on expression of bone markers during MC3T3-E1 osteoblastic cell differentiation. J Nutr Biochem 2003;14:342-9.
16. Khalil DA, Lucas EA, Smith BJ, Soung DY, Devareddy L, Juma S, et al. Soy isoflavones may protect against orchidectomy-induced bone loss in aged male rats. Calcif Tissue Int 2005;76:56-62.
17. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Met 1983;65:55-63.
18. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
19. Yamaguchi M, Oishi H, Suketa Y. Stimulatory effect of zinc on bone formation in tissue culture. Biochem Pharmacol 1987;36:4007-12.
20. Armour KE, Ralston SH. Estrogen upregulates endothelial constitutive nitric oxide synthase expression in human osteoblast-like cells. Endocrinology 1998;139:799-802.
21. Frost HM, Jee WS. On the rat model of human osteopenias and osteoporoses. Bone Miner 1992;18:227-36.